Open Lobectomy for Patients with Stage I Non-Small Cell Lung Cancer

Because the tumor is contained within a foci of lung parenchyma, the foundation of treatment of stage I non-small cell lung cancer is complete resection of the neoplasm and achieving microscopically negative margins. The choice of operation is crucial. Because of its more favorable local recurrence and 5-year survival rates, lobectomy with mediastinal lymphadenectomy is the gold standard for treating patients with clinical stage I non-small cell lung cancer who have sufficient cardiopulmonary reserve, including older patients.